Related references
Note: Only part of the references are listed.The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer
Zhigui Li et al.
SCIENTIFIC REPORTS (2018)
Impact of sex on prognostic host factors in surgical patients with lung cancer
Zoe Wainer et al.
ANZ JOURNAL OF SURGERY (2017)
EAdjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
Mark G. Kris et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value
Jun-Tao Yao et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients
Yu Yu et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy
Arnoud J. Templeton et al.
EUROPEAN UROLOGY (2016)
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Exosomal proteins as prognostic biomarkers in non-small cell lung cancer
B. Sandfeld-Paulsen et al.
MOLECULAR ONCOLOGY (2016)
The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer
Feng Jin et al.
ONCOTARGETS AND THERAPY (2016)
Circulating free DNA concentration is an independent prognostic biomarker in lung cancer
Claire Tissot et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
Sarah Burdett et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes
Chad Tang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
Donald C. McMillan
CANCER TREATMENT REVIEWS (2013)
The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer
Graeme J. K. Guthrie et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Lymphopenia is an Independent Predictor of Inferior Outcome in Clear Cell Renal Carcinoma
Sunil Saroha et al.
JOURNAL OF UROLOGY (2013)
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
Satoshi Teramukai et al.
EUROPEAN JOURNAL OF CANCER (2009)
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer
Khaled M. Sarraf et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2008)
Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features
Marie Wislez et al.
CLINICAL CANCER RESEARCH (2007)
Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection
Hiroshi Sugimura et al.
ANNALS OF THORACIC SURGERY (2007)
4-year mortality in patients with non-small-cell lung cancer: Development and validation of a prognostic index
Francois Blanchon et al.
LANCET ONCOLOGY (2006)
Share Paper
